SNPS.NASDAQSynopsys INC

Form 4: Synopsys Executive Chair Aart de Geus Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 2nd and 3rd, 2024, according to a Form 4 filing with the SEC.

Summary

  • A Form 4 filing reveals that Aart de Geus, the Executive Chair of Synopsys Inc. (SNPS), engaged in transactions involving Synopsys common stock on July 2nd and 3rd, 2024.
  • De Geus exercised non-qualified stock options to acquire 4,340 shares on July 2nd and 2,789 shares on July 3rd at an exercise price of $89.76 per share.
  • Concurrently, De Geus sold 4,340 shares on July 2nd at a weighted average price of $610.2529 and 2,789 shares on July 3rd at a weighted average price of $610.9402.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 25, 2024.
  • Following these transactions, De Geus directly owns 106,983 shares of Synopsys common stock.
  • Additionally, De Geus indirectly owns 122,240 shares through a Family Trust, 14,500 shares through a Partnership, and 186,551 shares through a Separate Prop Tr.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive, with no inherent positive or negative sentiment. It reflects standard corporate governance and compliance procedures.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a pre-arranged Rule 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

  • Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
  • The exercise of stock options and subsequent sale of shares is a typical wealth management strategy for executives.
  • The reported weighted average sale prices are within a normal range for Synopsys stock, given recent trading activity.
  • Comparable companies in the software and technology sector, such as Cadence Design Systems (CDNS) and Ansys (ANSS), also see regular Form 4 filings related to executive stock transactions.

Key Dates

DateDescription
12/12/2019Date Non-Qualified Stock Options were granted
03/25/2024Date of adoption of Rule 10b5-1 trading plan
07/02/2024Date of stock option exercise and share sale
07/03/2024Date of stock option exercise and share sale
07/05/2024Date of Form 4 filing
12/12/2025Expiration date of Non-Qualified Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.